Company intelligence / Profile preview

LifeSci Acquisition II

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

LifeSci Acquisition II was a special purpose acquisition company (SPAC) created to identify and merge with a private company in the healthcare sector. In October 2021, it merged with Science 37, a company specializing in decentralized clinical trial technology. Upon merger, Science 37 became the public company and LifeSci Acquisition II ceased to exist independently.

Industry: Investors

Beyond the preview

Go deeper on LifeSci Acquisition II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LifeSci Acquisition II.

Explore the full profile